SCHEMBL4932007

SCHEMBL4932007

CCOC(=O)c1cc(-c2ccc(NC(=O)OC(C)(C)C)cn2)n(-c2cnccn2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.41
RAB9A P51151 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
KMT2A Q03164 3/20 0.39
NAMPT P43490 2/20 0.39
HPGD P15428 1/20 0.38
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
GAA P10253 2/20 0.37
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP17A1 P05093 2/20 0.36
BCL2 P10415 1/20 0.35
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
CHRNA7 P36544 1/20 0.34
SREBF2 Q12772 1/20 0.34
USP2 O75604 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
FAAH O00519 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4923338 0.88 NAMPT (0.41) NAMPTCYP17A1BCL2SREBF2GPR119
SCHEMBL4929002 0.87 KMT2A (0.46) KMT2ANAMPTALDH1A1MEN1GAA
SCHEMBL5518699 0.86 NAMPT (0.42) NPC1RAB9ANAMPTCYP17A1BCL2
SCHEMBL5522115 0.84 NAMPT (0.39) NAMPTCYP17A1BCL2GPR119
SCHEMBL4923164 0.82 KMT2A (0.43) NPC1RAB9ASMN1; SMN2KMT2AHPGD
SCHEMBL4932361 0.80 CYP1A2 (0.38) NAMPTALDH1A1BCL2GPR119
SCHEMBL16876859 0.75 CA9 (0.47) NPC1RAB9ASMN1; SMN2KMT2AHPGD
SCHEMBL4931448 0.75 KMT2A (0.46) KMT2AALDH1A1MEN1GAAMAPT
SCHEMBL14270461 0.75 RXFP1 (0.34) NPC1RAB9ASMN1; SMN2KMT2AALDH1A1
SCHEMBL4934933 0.75 NAMPT (0.48) NAMPTALDH1A1BCL2GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064682-A1 Pyrazole Derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2008-03-13 US disclosed
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
EP-1762568-A1 PYRAZOLE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-03-14 EP disclosed
EP-1698626-A1 AMIDOPYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064682-A1 Pyrazole Derivatives NAT1, AR, CBR3 NPC1 2133/4885RAB9A 2200/4885SMN1; SMN2 3660/4885
US-20070219210-A1 Amidopyrazole Derivative PTGER1, PTGS1, PTGER2 NPC1 4459/4885RAB9A 4058/4885SMN1; SMN2 4048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.